Downstream Processing Featured Articles

81. iBio, Inc. And GE Healthcare Form New Global Alliance 7/26/2012

    iBio, Inc., and GE Healthcare, the healthcare business of GE, announced recently a new global alliance to commercialize plant-based technologies for the manufacture of biopharmaceuticals and vaccines.

82. Tiny Capsule Effectively Kills Cancer Cells 2/6/2013

    A tiny capsule invented at a UCLA lab could go a long way toward improving cancer treatment.

83. OHSU Doernbecher Scientists First To Grow Liver Stem Cells In Culture, Transplant Them With Demonstrated Therapeutic Benefit 2/25/2013

    For decades scientists around the world have attempted to regenerate primary liver cells known as hepatocytes because of their numerous biomedical applications, including hepatitis research, drug metabolism and toxicity studies, as well as transplantation for cirrhosis and other chronic liver conditions.

84. 'Patch on a Chip' under development by Axon Instruments 11/1/2000
    New fabrication method will allow thousands of simultaneous patch clamp recordings...
85. First Patient Treated In Genelux Phase I Trial With GL-ONC1 At Memorial Sloan Kettering Cancer Center 2/6/2013

    Genelux Corporation, a clinical-stage biopharmaceutical company developing vaccinia virus-based cancer therapies and companion diagnostics, today announced that researchers at Memorial Sloan Kettering Cancer Center (MSKCC) in New York treated the first patient in a Phase I clinical trial of GL-ONC1 in people with malignant pleural effusion, a complication that occurs in about 30 percent of lung cancers.

86. Bioresearch Online Interview With Kirby Pilcher And Dr. George Rodrigues, ARTEL 3/20/2007
    The editorial staff recently sat down with Kirby Pilcher and Dr. George Rodrigues to discuss liquid handling quality assurance and the solutions that are available to avoid potentially expensive and risky pipetting disasters. Kirby is the President and Dr. George Rodrigues the Senior Scientific Manager of ARTEL in Westbrook, ME. Enjoy the discussion
87. FDA Approves New Combination Vaccine That Protects Children Against Two Bacterial Diseases 6/14/2012

    The U.S. Food and Drug Administration recently approved Menhibrix, a combination vaccine for infants and children ages 6 weeks through 18 months, for prevention of invasive disease caused by Neisseria meningitidis serogroups C and Yand Haemophilus influenzae type b.

88. FDA Approves New Seasonal Influenza Vaccine Made Using Novel Technology 1/16/2013

    The U.S. Food and Drug Administration recently announced that it has approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology. Flublok is approved for the prevention of seasonal influenza in people 18 through 49 years of age.

89. Rockland Immunochemicals Acquires TrueBlot Product Line 12/13/2012

    Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, assay development, and preclinical studies, recently announced the acquisition of the TrueBlot IP/Western blot product line from eBioscience, Inc., an Affymetrix company.

90. Standardized Extractables Testing Advances Single Use Adoption 6/3/2015

    The Standardized Extractables Testing Protocol For Single-Use Systems In Biomanufacturing written by BPOG members last year establishes a foundation from which to create a standardized approach to extractables testing. However, since its release, there have been some questions and discussions about how to effectively implement the protocol.